Objective-To investigate the effect of oxidative stress on ischemia-induced neovascularization in copper-zinc (CuZn) superoxide dismutase (SOD)-deficient mice. Methods and Results-In the vascular wall, CuZnSOD is essential for protecting against excessive oxidative stress and maintaining endothelial function. However, its specific role for the development of new vessels in response to ischemia is unknown. After surgically induced hind limb ischemia, CuZnSOD-deficient mice showed impaired neovascularization, as assessed by blood flow recuperation (laser Doppler) and capillary density in the ischemic muscles. This was associated with increased levels of oxidative stress in ischemic tissues and peripheral blood, together with reduced plasmatic NO production. CuZnSOD-deficient mice demonstrated an important reduction in the number of endothelial progenitor cells (EPCs) in the bone marrow and spleen. Moreover, EPCs isolated from CuZnSOD-deficient mice showed increased oxidative stress levels, decreased NO production, and a reduced ability to migrate and integrate into capillary-like networks. Importantly, the functional activities of CuZnSOD-deficient EPCs were rescued after treatment with the SOD-mimetic Tempol (a membrane-permeable radical scavenger) or the NO donor sodium nitroprusside (SNP). Moreover, the neovascularization defect in CuZnSOD-deficient mice could be rescued by wild-type (but not CuZnSOD-deficient) EPC supplementation. Conclusion-Protection against oxidative stress by CuZnSOD may be essential for EPC function and reparative neovascularization after ischemia. (Arterioscler Thromb Vasc Biol. 2010;30:2173-2181.)
I n patients with cardiovascular diseases, the capacity of the organism to develop new blood vessels (neovascularization) constitutes an important adaptive mechanism against ischemia. 1 Interestingly, several risk factors that promote the development of atherosclerotic vascular diseases, such as aging, hypercholesterolemia, diabetes mellitus, cigarette smoking, and hypertension, are also associated with reduced neovascularization in response to ischemia. [2] [3] [4] [5] A common feature of all these cardiovascular risk factors is increased production of reactive oxygen species (ROS). 6 Although low levels of ROS can serve as signaling agents promoting vascular integrity, 7 higher levels have been associated with endothelial dysfunction and impaired angiogenesis in different models. 8, 9 Excessive oxidative stress also leads to reduced bioactivity of NO, 6 an essential mediator of endothelial cell migration and ischemia-induced neovascularization. 10, 11 The oxidative stress level in the vascular endothelium is the result of a balance between the rate of ROS formation and the rate of ROS removal by endogenous antioxidant enzymes, such as superoxide dismutases (SODs). The pre-dominant isoform of SOD within blood vessels is copper-zinc (CuZn) SOD (SOD1), accounting for 50% to 80% of total SOD activity. 12 CuZnSOD is located within the cytosol and the nucleus and is thought to be expressed in all mammalian cells. The functional importance of CuZnSOD within blood vessels has been demonstrated in homozygous CuZnSODdeficient mice, which present increased superoxide levels and altered responsiveness in both large arteries and microvessels. 12 In addition, heterozygous CuZnSOD deficiency produces increases in superoxide levels and marked impairment of endothelial function with aging. 13 However, the specific role of CuZnSOD for the reparative development of new vessels in response to ischemia is unknown.
Recent studies 14, 15 suggest that postnatal neovascularization does not exclusively rely on the sprouting of mature endothelial cells in preexisting vessels (angiogenesis); it also involves the contribution of bone marrow-derived circulating endothelial progenitor cells (EPCs). Circulating EPCs in adults can home to ischemic tissues and contribute to the formation of new blood vessels. 16 EPCs express higher levels of antioxidative enzymes and enhanced protection against oxidative stress compared with mature endothelial cells. 17, 18 However, cardiovascular risk factors involving increased oxidative stress are associated with impaired EPCs in patients with coronary artery disease. 19 Moreover, the functional activities of EPCs are impaired in conditions of increased oxidative stress. 20, 21 Because CuZnSOD has an essential role in the protection of the vasculature from oxidative stress, we investigated the effect of CuZnSOD deficiency on oxidative stress levels and ischemia-induced neovascularization in a murine model of hind limb ischemia. Our data indicate that CuZnSOD deficiency is associated with impaired neovascularization after ischemia. We also demonstrate that CuZnSOD-deficient mice have a reduced number of EPCs and that these EPCs exhibit increased oxidative stress and impaired functional activities.
Methods
An expanded version of the methods is available in the supplemental data (available online at http:/atvb.ahajournals.org).
Experimental Animals
Male and female mice, aged 6 to 8 weeks, were derived from breeding pairs of heterozygous CuZnSOD-deficient (B6;129S-SOD1 tm1Leb /J) mice obtained from Jackson Laboratory, Bar Harbor, Me. Two groups of mice were studied: homozygous CuZnSODdeficient (CuZnSOD Ϫ/Ϫ ) mice and wild-type (CuZnSOD ϩ/ϩ ) littermates. No difference was observed between male and female mice for the different parameters investigated. The genotyping of each mouse was assessed by PCR of DNA isolated from tail biopsy samples, as described on the Jackson Laboratory web site (supplemental Figure IA ). The expression of other antioxidant and prooxidant enzymes in hind limb muscles was similar in both groups of mice (supplemental Figure IB ).
Murine Ischemic Hind Limb Model and Blood Pressure Monitoring
The protocol was approved by the Comité Institutionnel de Protection des Animaux of the Centre Hospitalier de l'Université de Montréal. Unilateral hind limb ischemia was surgically induced as previously described. 5 Hind limb perfusion was measured with a laser Doppler perfusion imager system (Moor Instruments Ltd, Axminster, England). To account for variables such as ambient light and temperature, the results are expressed as the ratio of perfusion in the left (ischemic) versus the right (non-ischemic) hind limb. Hind limb ischemic damage was evaluated clinically using a grading scale ranging from 0 to 4. Blood pressure was monitored with a tail cuff pressure instrument (model BP-2000; Visitech Systems, Apex, NC).
Tissue Preparation and Immunochemistry
For immunohistochemistry, whole ischemic hind limbs were immediately fixed in tissufix (Chaptec, Montreal, Qc, Canada). Endothelial cells were identified by immunostaining for platelet endothelial cell adhesion molecule-1, or CD31, with a rat monoclonal antibody directed against mouse CD31 (Pharmigen, San Diego, Calif). Arterioles were identified using a commercially available kit (modified Verhoeff-Van Gieson elastic stain kit; Sigma, St Louis, Mo). To evaluate local oxidative stress levels in ischemic muscles, an antibody against nitrotyrosine (Upstate, Lake Placid, NY) was used. The specificity of the test was confirmed by preincubating the antibody with 10 mmol/L nitrotyrosine (data not shown). To evaluate superoxide production in ischemic muscles, dihydroethidium (DHE) fluorescence labeling was performed. The specificity of the test was confirmed by incubating the section with polyethyleneglycol-SOD (PEG-SOD), 500 U/mL, for 1 hour (data not shown). The intensities of fluorescence were measured and analyzed using computer-based software (Metamorph, Silicon Valley, Calif) with the same threshold for all sections.
Western Blot Analysis
Proteins were extracted from hind limb muscles, and the following antibodies were used for Western blots: catalase (1:500; Calbiochem, Merck KGaA, Darmstadt, Germany), manganese SOD (1:1000; Cell Signaling Technology, Boston, Mass), gp91phox (1:500; Transduction Laboratories, Franklin Lakes, NJ), NOX4 (1:200; Santa Cruz Biotechnology, Santa Cruz, Calif), and ␣-tubulin (1:200; Santa Cruz Biotechnology).
Plasma NO and Total 8-Isoprostane
NO production in mice plasma samples was determined indirectly by measuring the concentration of the stable end products, nitrate and nitrite, using a commercial kit (R&D Systems Inc, Minneapolis, Minn) based on the Griess reaction. Total (free and esterified) 8-isoprostane was quantified in samples and standards using a commercially available enzyme immunoassay kit (Cayman Chemical Co, Ann Arbor, Mich). Values are expressed as picograms of 8-isoprostane per milliliter of total plasma protein.
Fluorescence-Activated Cell Sorter Analysis of Circulating Progenitor Cells
The percentages of progenitor cells contained in the total viable cell population derived from the spleen were measured and analyzed by fluorescence-activated cell sorter (FACSCalibur flow cytometer; Becton Dickenson, Oakville, ON) using the following fluorescence-coupled cell markers: CD34 -fluorescein isothiocyanate (FITC), vascular endothelial growth factor (VEGF) receptor 2 (Flk1)-phycoerythrin (PE), and CD117 (c-kit)-allophycocyanin (APC) (eBioscience, San Diego, Calif). Cell phenotypes were determined by analysis of 300 000 events.
EPC Isolation and Characterization
Mononuclear cells were mechanically isolated from the spleen or the femur, tibia, and humerus by flushing the bone marrow cavities using culture medium. After red blood cell lysis and washing, mononuclear cells were plated on 0.05% fibronectin (Sigma) and cultured in complete medium 200 containing 20% FBS. After 4 days in culture, nonadherent cells were removed by thorough washing with PBS. Adherent cells were stained with 1,1Ј-dioctadecyl-3,3,3Ј,3Ј tetramethylindocarbocyanine perchlorate-acetylated low-density lipoprotein (DiI-acLDL) (2.5 g/mL, for 1 hour; Invitrogen, Carlsbad, Calif) and FITC-labeled lectin Bandeiraea simplicifolia, 10 g/mL, for 1 hour (Sigma). Spindle-shaped cells were observed, and most adherent cells (95%) were double positive for the uptake of DiI-acLDL and binding of FITC-labeled lectin. These cells migrated in response to VEGF stimulation and were capable of incorporating into a network of tubular-like structures when cocultured with mature endothelial cells. Based on these morphological and functional characteristics, these cells were defined as EPCs.
Detection of Intracellular ROS and NO in EPCs
Intracellular ROS generation was assessed with a fluorometer using 2Ј, 7Ј-dichlorofluorescein diacetate (Sigma). The specificity of the test was confirmed using the ROS scavenger Tiron, 5 mmol/L. Dihydroethidium (DHE) was used to evaluate the presence of superoxide anion oxygen radicals. The specificity of the test was confirmed using the superoxide inhibitor PEG-SOD, 500 U/mL. The measurement of free NO and NO synthase (NOS) activity in EPCs was assessed with diaminofluorescein-2 diacetate, a nonfluorescent cell-permeable reagent (Cell Technology Inc, Mountain View, Calif).
Cell Migration Assay
Cell migration was assessed using a modified Boyden chamber assay. Inserts were placed in a 24-well plate containing M200 with 50 ng/mL VEGF. EPCs (15 000) were added to the upper chamber of the inserts in M200, with 0.1% FBS, in the presence or absence of the SODmimetic Tempol (a membrane-permeable radical scavenger), 0.1 mmol/L, or the NO donor sodium nitroprusside (SNP), 0.1 mmol/L.
EPC Adhesion to Endothelial Cells
A monolayer of human umbilical vein endothelial cells (HUVECs) was prepared 48 hours before the assay by plating 2ϫ10 5 cells (passage 2-5) in each well of 24-well plates. HUVECs were pretreated for 12 hours with tumor necrosis factor ␣, 1 ng/mL (BD Biosciences, San Diego, Calif). Cells were stained with 4Ј,6Јdiamidino-2-phenylindole (DAPI) and fixed with 2% paraformaldehyde. EPCs were labeled with DiI-acLDL, and 11 000 EPCs were added to each well and incubated for 3 hours at 37°C in the presence or absence of the SOD-mimetic Tempol, 0.1 mmol/L. Non-attached cells were gently removed with PBS, and adherent EPCs were fixed with 2% paraformaldehyde and counted in 3 random fields. The data are presented as a ratio of the number of adherent EPCs/HUVECs per field (ϮSEM).
Tubular-like Formation on Matrigel
A total of 4000 EPCs, labeled for 1 hour with DiI-acLDL, were co-plated with 14 000 HUVECs in 96-well plates that were precoated with 50 L of growth factor-reduced Matrigel matrix (BD Biosciences) and cultured at 37°C for 6 hours with 50 ng/mL VEGF in the presence or absence of the SOD-mimetic Tempol, 0.1 mmol/L. Tubular-like structures were photographed, and the number of incorporated EPCs was determined in 6 random fields. A tube was defined as a straight cellular segment connecting 2 cell masses (nodes). No difference in the total number of tubes or in tube length was observed between the different groups (data not shown). The data are presented as number (ϮSEM) of incorporated EPCs per tube.
CD117 ؉ Cell Therapy
Bone marrow mononuclear cells were isolated from the femur, tibia, and humerus of CuZnSOD ϩ/ϩ or CuZnSOD Ϫ/Ϫ donors by flushing the bone marrow cavities using culture medium. Bone marrow cells reacting to anti-CD117 (rat anti-mouse; eBioscience) were sorted using immunomagnetic beads (Dynabeads M-450 coupled to sheep anti-rat IgG; DYNAL, Oslo, Norway). Twenty-four hours after the surgical induction of hind limb ischemia, 5ϫ10 5 freshly isolated CD117 ϩ cells were introduced into CuZnSOD-deficient mice by tail-vein injection. The control group consisted of CuZnSODdeficient mice that were injected with saline only.
Statistical Analysis
All results are expressed as the meanϮSEM. Statistical significance was evaluated using an unpaired t test or a one-way ANOVA, followed by the Newman-Keuls post-hoc test for multiple group comparisons. PϽ0.05 indicated statistical significance.
Results

Impaired Ischemia-Induced Neovascularization in CuZnSOD-Deficient Mice
Blood flow perfusion was evaluated by serial laser Doppler perfusion imager studies after the induction of hind limb ischemia ( Figure 1A ). Immediately after the surgery (day 0), Doppler flow ratios were reduced to 0.14Ϯ0.03 in wild-type (WT) and 0.12Ϯ0.02 in CuZnSOD KO mice, indicating that the severity of the induced ischemia was similar in both groups. However, the recuperation of blood flow after ischemia was significantly impaired in CuZnSOD-deficient mice. At day 7 after surgery, Doppler flow ratios were significantly reduced in CuZnSOD KO compared with WT mice (0.56Ϯ0.04 versus 0.68Ϯ0.02; PϽ0.05); and the difference in blood flow recuperation between the 2 groups was even more apparent at day 21 after surgery (0.67Ϯ0.04 versus 0.84Ϯ0.01; PϽ0.01). Systolic blood pressure was similar in the 2 groups at baseline and at 1, 2, and 3 weeks after surgery (supplemental Figure IIA) . Figure 1B shows representative results of CD31 immunostaining in ischemic muscles at day 21 after surgery (left). Quantification of CD31-positive cells (right) demonstrates that the capillary density in ischemic muscles is significantly reduced in CuZnSOD KO compared with WT mice (0.64Ϯ0.02 versus 0.90Ϯ0.03 capillaries per muscle fiber; PϽ0.05). Similarly, arteriolar density was also significantly reduced in the ischemic muscles of CuZnSOD KO mice (supplemental Figure IIB) . In the non-ischemic hind limb, capillary and arteriolar densities remained unchanged over time and were not different between groups (data not shown). Clinically, the reduced blood flow recuperation in CuZnSOD KO mice was associated with an important increase in hind limb ischemic damage at day 21 after ischemia (supplemental Figure IIC) .
Oxidative Stress Levels and NO Production in CuZnSOD-Deficient Mice
Because excessive oxidative stress has been associated with impaired angiogenesis in different situations, we compared oxidative stress levels in ischemic muscles of CuZnSOD KO and WT mice. Figure 2A shows representative results of nitrotyrosine immunostaining (left), an indicator of protein nitration by ROS. Figure 2B shows results for DHE, an indicator of superoxide levels. Quantification of relative fluorescences (right) demonstrates that both markers of oxidative stress were significantly increased in the ischemic muscles of CuZnSOD KO compared with WT mice. Systemically, we also demonstrate that CuZnSOD deficiency is associated with a significant increase of plasmatic concentration of isoprostanes (supplemental Figure IIIA) , an in vivo marker of oxidative stress. Increased oxidative stress has also been associated with reduced bioactivity of NO, an important angiogenic factor. Herein, we demonstrate that CuZnSODdeficient mice have a significant reduction of NO production in the serum, as evaluated by the concentration of the stable end products, nitrate and nitrite, based on the Griess reaction (supplemental Figure IIIB) .
EPC Levels in CuZnSOD-Deficient Mice
To identify the potential mechanisms involved in the detrimental effect of CuZnSOD deficiency on ischemia-induced neovascularization, we quantified the number of EPCs in the different animal groups at baseline (day 0) and at day 7 after hind limb ischemia. Bone marrow and spleen EPCs were isolated in culture and shown to endocytose acLDL and bind Bandeiraea simplicifolia-lectin ( Figure 3A) . We found that the number of bone marrow EPCs is consistently reduced in CuZnSOD KO compared with WT mice, both at baseline and after ischemia ( Figure 3B ). On the other hand, spleen EPCs were only reduced after ischemia in CuZnSOD KO compared with WT mice, suggesting a potential defect in EPC mobilization in KO mice ( Figure 3C ). The percentage of circulating progenitor cells contained in the total viable cell population derived from the spleen was also measured by fluorescenceactivated cell sorter analysis at day 7 after ischemia using the cell markers CD34, VEGF receptor 2, and CD117 ( Figure  3D ). Similar to EPCs isolated in culture, the number of peripheral circulating progenitor cells was also significantly reduced in CuZnSOD-deficient mice.
Oxidative Stress, NO, and Angiogenic Activities of CuZnSOD-Deficient EPCs
ROS and superoxide generation were measured in EPCs isolated from the bone marrow using DCFH-DA and DHE, respectively. We found that CuZnSOD deficiency is associated with a significant increased generation of ROS ( Figure  4A ) and superoxide ( Figure 4B ) in bone marrow EPCs. We also demonstrate that this increased oxidative stress is associated with decreased NO production ( Figure 4C ) together with an important impairment of EPC functional activities ( Figure 5 ). CuZnSOD-deficient EPCs exhibited significant reduction in VEGF-induced migration ( Figure 5A ). More- . Effect of CuZnSOD deficiency on EPC number. A, Bone marrow EPCs were identified using DiI-acLDL, lectin-FITC, and DAPI stains. Cells positive for all 3 dyes were counted as EPCs. B and C, Quantification was performed for EPCs isolated from the bone marrow (B) or the spleen (C) at baseline (day 0) and at day 7 after hind limb ischemia. *PϽ0.05 vs WT mice at baseline, and #PϽ0.05 vs WT mice after ischemia. D, The percentage of circulating progenitor cells derived from the spleen was measured by fluorescenceactivated cell sorter analysis (300 000 events) using the surface markers CD34, VEGFR2, and CD117. After appropriate gating (R1) to over, we found that CuZnSOD-deficient EPCs are significantly impaired in their ability to adhere to a HUVEC monolayer activated with tumor necrosis factor ␣ ( Figure 5B and D). Finally, in a coculture of EPCs and HUVECs on Matrigel, CuZnSOD deficiency was associated with a significant reduction in the capacity of EPCs to integrate into tubular-like structures ( Figure 5C and E) . Importantly, the functional activities of CuZnSOD-deficient EPCs were rescued after treatment with the SOD-mimetic Tempol (Figure 5A-E) . Moreover, impaired migratory activity of CuZnSOD Ϫ/Ϫ EPCs could be significantly improved after treatment with the NO donor SNP (supplemental Figure IV) .
WT EPC Supplementation Rescues Neovascularization in CuZnSOD-Deficient Mice
To further evaluate the potential role of EPC dysfunction in the impairment of neovascularization associated with CuZn-SOD deficiency, we performed rescue experiments using a CD117 ϩ stem cell fraction isolated from the bone marrow of WT or CuZnSOD-deficient mice. CD117 ϩ cells have a high endothelial differentiation potential in vitro and are thought to play a key role in neovascularization induced by bone marrow cell therapy. 22 Herein, we show that WT CD117 ϩ cell therapy can rescue blood flow recuperation after hind limb ischemia in CuZnSOD-deficient mice ( Figure 6A) . Moreover, at the microvascular level, capillary density was also significantly improved in CuZnSOD-deficient mice treated with WT CD117 ϩ cells compared with CuZnSODdeficient mice treated with saline only (Figure 6B ). Interestingly, treatment with CuZnSOD-deficient CD117 ϩ cells EPCs were isolated from the bone marrow of CuZn-SOD Ϫ/Ϫ or WT mice. A, VEGF-induced migration was assessed using a modified Boyden chamber assay. B and D, To assess EPC adhesion, EPCs were labeled with a DiI fluorescent marker (red) and allowed to adhere to a monolayer of tumor necrosis factor ␣-stimulated HUVECs (blue, nuclear stain DAPI). C and E, To assess integration into tubular-like structures, fluorescentlabeled EPCs (red) were coplated with HUVECs (transparent) to form tubular-like structures on Matrigel. Rescue experiments were performed with the SOD-mimetic Tempol, 0.1 mmol/L. EPCs from 5 to 7 different mice per group were tested. Data are given as meanϮSEM. *PϽ0.01 vs WT control EPCs, and @PϽ0.01 vs CuZnSOD Ϫ/Ϫ EPCs.
failed to improve neovascularization in CuZnSOD-deficient mice ( Figure 6A and B ).
Discussion
To our knowledge, the present study provides the first evidence of the essential function of CuZnSOD for the reparative neovascularization process in response to ischemia. CuZnSOD has an important role in limiting increases in superoxide levels in different tissues. Accordingly, a reduction in CuZnSOD activity leads to increased oxidative stress and has a detrimental effect in different clinical situations. For example, neuronal cell injury and edema formation after transient focal cerebral ischemia are increased in CuZnSODdeficient mice. 23, 24 Similarly, renal injury in the context of ischemia/reperfusion 25 or diabetes 26 is significantly increased in CuZnSOD-deficient mice. CuZnSOD deficiency has also been associated with ovarian, 27 retinal, 28 and hepatic 29 dysfunction. However, in the cardiovascular system, a previous study 30 did not show any significant alteration of post-ischemic myocardial contractile function in heterozygous CuZnSODdeficient mice. Herein, we studied homozygous CuZnSOD-deficient mice to precisely define the role of CuZnSOD for the modulation of neovascularization in a well-described model of hind limb ischemia. 31 Oxidative stress is thought to have a double-edge effect on the modulation of neovascularization in response to ischemia. On one hand, a minimal level of ROS seems to be needed for the promotion of angiogenesis in physiological conditions and healthy animals. For instance, NADPH oxidase activity is required for a hypoxia-stimulated increase in VEGF expression and retinal neovascularization. 32 In addition, Nox2containing NADPH oxidase plays an important role in VEGF-induced angiogenesis 33 and in neovascularization after hind limb ischemia. 34 On the other hand, excessive production of ROS in pathological conditions leads to cellular toxicity and has been associated with impaired angiogenesis in different models. 8, 9, 35 Moreover, cardiovascular risk factors with increased oxidative stress levels, such as aging, 2 diabetes, 3 hypercholesterolemia, 4 and cigarette smoking, 5 have consistently been associated with impaired neovascularization in response to ischemia. The results of the present study confirm the detrimental effect of excessive oxidative stress in the modulation of neovascularization in response to ischemia. We show that CuZnSOD deficiency is associated with increased oxidative stress and a significant impairment of ischemia-induced neovascularization, as demonstrated by a slower rate of blood flow recovery after ischemia and reduced capillary and arteriolar densities in ischemic muscles.
The mechanisms by which CuZnSOD deficiency leads to impaired ischemia-induced neovascularization are potentially diverse. Ischemic tissues are characterized by high levels of inflammatory cytokines, which activate ROS production. 36 In this context, CuZnSOD activity can act as a defense mechanism against excessive oxidative stress. Consistent with this finding, we found that superoxide and ROS production was significantly increased in ischemic tissues of CuZnSODdeficient mice compared with controls. It is conceivable that high levels of ROS in CuZnSOD-deficient mice negatively modulate the function of endothelial cells in ischemic tissues, which would, in turn, contribute to impair angiogenesis. In fact, endothelial dysfunction in both large arteries and microvessels has previously been described in CuZnSODdeficient mice. 12 It is also possible that excessive ROS production in ischemic tissues interferes with the activity of pro-angiogenic factors, such as VEGF. 8, 9 In the current study, we propose that a major factor involved in the neovascularization defect of CuZnSODdeficient mice is EPC dysfunction. The importance of EPCs for the development of neovessels in different physiological and pathological situations has recently been recognized. 14 -16 Herein, we demonstrate that the number of EPCs is significantly reduced in CuZnSOD-deficient mice, both in the bone marrow and in the spleen. We also found that, compared with wild-type EPCs, CuZnSOD-deficient EPCs exhibit reduced angiogenic activities, including cellular migration, adhesion to mature endothelial cells, and integration into vascular structures. Finally, we show that WT (but not CuZnSODdeficient) EPC supplementation can rescue the impaired ischemia-induced neovascularization in CuZnSOD-deficient mice. Although the precise mechanisms involved in the Figure 6 . A and B, EPC supplementation in CuZnSOD-deficient mice. Twenty-four hours after the surgical induction of hind limb ischemia, 5ϫ10 5 CD117 ϩ cells freshly isolated from the bone marrow of WT or CuZnSOD KO mice were introduced into CuZnSOD-deficient mice by tail-vein injection. The control group consisted of CuZnSOD-deficient mice that were injected with saline only (S). Recuperation of blood flow perfusion (A) and capillary density (B) in ischemic muscles were assessed at day 21 using laser Doppler measurements and CD31 immunostaining, respectively. Data are given as meanϮSEM (nϭ7-12 per group). TH indicates therapy with CD117 ϩ cells isolated from WT mice (TH ϩ ) or from CuZnSOD KO mice (TH Ϫ ). *PϽ0.05 vs the control group (S), and #PϽ0.05 vs TH Ϫ . modulation of neovascularization by EPCs are still not fully elucidated, the paracrine or vascular supportive effects of EPCs could play a more important role than true vascular incorporation. 15 In the current study, the reduced production of the angiogenic factor NO that we documented in CuZnSOD-deficient EPCs could have contributed to impair neovascularization in response to ischemia.
EPCs are thought to exhibit increased resistance to oxidative stress compared with mature endothelial cells. It has been proposed that EPCs are enriched for the expression of genes encoding antioxidant proteins, such as catalase, glutathione peroxidase, and manganese SOD. This, in turn, results in low baseline ROS levels and a reduced sensitivity toward ROSinduced cell death. 17, 18 In the present study, we demonstrate for the first time the critical role of CuZnSOD for the modulation of oxidative stress in EPCs. Although CuZnSOD was not increased in EPCs compared with mature endothelial cells in previous reports, 17, 18 our results suggest that CuZn-SOD expression is nevertheless essential to protect against excessive ROS generation in EPCs and to preserve their angiogenic properties. Moreover, the fact that CuZnSODdeficient EPCs exhibit increased basal levels of ROS compared with WT EPCs indicates that other antioxidant enzymes, such as glutathione peroxidase and manganese SOD, cannot fully compensate for the absence of CuZnSOD.
The precise mechanisms by which CuZnSOD deficiency negatively modulates the number and functional activities of EPCs remain to be determined. However, previous studies 21, 37 have demonstrated that clinical situations that lead to increased oxidative stress levels are also associated with an impairment of EPC number and functions. Moreover, the inhibition of antioxidant enzymes in EPCs has previously been shown to increase ROS levels and impair EPC survival and migration. 17 Therefore, it is plausible that increased levels of ROS in CuZnSOD-deficient EPCs, as demonstrated by DCFH-DA and DHE staining, contribute to the decreased number and functional activity of EPCs. SODs are also involved in the modulation of NO bioactivity. It has been suggested that the release of NO from the endothelium is dependent on CuZnSOD, whereas extracellular (ec)SOD activity is thought to be required for the protection of NO as it diffuses through the vascular wall. 12 Herein, we found that NO production was significantly reduced in the serum and in EPCs of CuZnSOD-deficient mice. We also demonstrate that the impaired migratory activity of CuZnSOD-deficient EPCs can be rescued after treatment with the NO donor SNP. Interestingly, NO is an essential mediator of endothelial cell migration and VEGF-induced angiogenesis. 10, 11 Moreover, recent reports indicate that NO is an essential mediator of EPC mobilization and EPC functional activity. 38 Therefore, the decreased NO production that we documented in CuZnSOD-deficient mice could constitute a conceptual link between CuZnSOD deficiency, EPC dysfunction, and impaired ischemia-induced neovascularization.
In summary, our study demonstrates that CuZnSOD deficiency impairs postnatal neovascularization and blood flow recuperation after ischemia. We propose that this defect is at least partly because of increased levels of ROS, reduced NO production, and impairment of EPC number and functional activities. The finding that CuZnSOD is essential for EPC functions might have important clinical implications. Diabetic patients and patients with chronic heart failure exhibit defective levels of antioxidant enzymes, including CuZn-SOD. 39 -41 Therefore, CuZnSOD deficiency could contribute to explain reduced EPC numbers and impairment of EPC functional activities in patients with diabetes, 42 coronary artery disease, 19 and congestive heart failure. 43 In patients with these conditions, CuZnSOD modulation might represent a novel therapeutic avenue to restore EPC functions and neovascularization in those with severe ischemic vascular diseases.
